Cargando…

Loss of GRB2 associated binding protein 1 in arteriosclerosis obliterans promotes host autophagy

BACKGROUND: Arteriosclerosis obliterans (ASO) is a major cause of adult limb loss worldwide. Autophagy of vascular endothelial cell (VEC) contributes to the ASO progression. However, the molecular mechanism that controls VEC autophagy remains unclear. In this study, we aimed to explore the role of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Meng, Guo, Xiang-Jiang, Kan, Ke-Jia, Ni, Qi-Hong, Chen, Jia-Quan, Wang, Han, Qian, Xin, Xue, Guan-Hua, Deng, Hao-Yu, Zhang, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862813/ https://www.ncbi.nlm.nih.gov/pubmed/33323827 http://dx.doi.org/10.1097/CM9.0000000000001255

Ejemplares similares

HSPB1 Regulates Autophagy and Apoptosis in Vascular Smooth Muscle Cells in Arteriosclerosis Obliterans
por: Chen, Keqin, et al.
Publicado: (2022)

Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
por: Yuan, You-Yuan, et al.
Publicado: (2023)

Comparison of efficacy between trimetazidine and cilostazol in the treatment of arteriosclerosis obliterans in lower extremity
por: Hu, Min, et al.
Publicado: (2019)

Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans
por: Yong, Jun, et al.
Publicado: (2019)

Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Xiao, Deshuang, et al.
Publicado: (2022)

Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans
por: Liu, Yulian, et al.
Publicado: (2023)

Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
por: Zhou, Yu, et al.
Publicado: (2023)

Expression and clinical significance of HSP27 and its phosphorylation in lower extremity arteriosclerosis obliterans
por: Bai, Junqing, et al.
Publicado: (2020)

Retracted: Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Ameliorative effects of the traditional Chinese medicine formula Qing-Mai-Yin on arteriosclerosis obliterans in a rabbit model
por: Zhang, Lei, et al.
Publicado: (2020)

Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans
por: Zhou, Ruhang, et al.
Publicado: (2021)

Retracted: Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans
por: Healthcare Engineering, Journal of
Publicado: (2023)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans
por: Liu, Zhenjie, et al.
Publicado: (2020)

Predictive Value of Contrast-Enhanced Ultrasound in Chemical Lumbar Sympathectomy for End-Stage Arteriosclerosis Obliterans of the Lower Extremities
por: Wu, Yue, et al.
Publicado: (2022)

The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis
por: Yang, Bo, et al.
Publicado: (2023)

MicroRNA-30a-3p: a potential noncoding RNA target for the treatment of arteriosclerosis obliterans
por: Zhang, Mao, et al.
Publicado: (2023)

Effect of Recombinant Netrin-1 Protein Combined with Peripheral Blood Mesenchymal Stem Cells on Angiogenesis in Rats with Arteriosclerosis Obliterans
por: Zeng, Jie, et al.
Publicado: (2022)

Effects of Drug-Coated Balloon Therapy on CT Imaging Results and Levels of Vascular Inflammatory Cytokines in Patients with Arteriosclerosis Obliterans Lesions
por: Yang, Yanlin
Publicado: (2022)

The Macronova in GRB 050709 and the GRB-macronova connection
por: Jin, Zhi-Ping, et al.
Publicado: (2016)

Arteriosclerosis
Publicado: (1925)

Arteriosclerosis
Publicado: (1913)

MicroRNA-31 promotes arterial smooth muscle cell proliferation and migration by targeting mitofusin-2 in arteriosclerosis obliterans of the lower extremitie
por: Huang, Shuichuan, et al.
Publicado: (2018)

Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4/NF-κB signaling pathway
por: Lou, Xinjiang, et al.
Publicado: (2019)

Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial
por: Yao, Wei, et al.
Publicado: (2020)

Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report
por: Zhou, Bo, et al.
Publicado: (2020)

Increased Level of Tim-3(+)PD-1(+)CD4(+)T Cells With Altered Function Might Be Associated With Lower Extremity Arteriosclerosis Obliterans
por: Cui, Liyuan, et al.
Publicado: (2022)

A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol
por: Ma, Xiao-Wei, et al.
Publicado: (2012)

EXPERIMENTAL ARTERIOSCLEROSIS
por: Pearce, Richard M., et al.
Publicado: (1906)

The Biology of Arteriosclerosis
por: Pappenheimer, Alwin M.
Publicado: (1938)

The Treatment of Arteriosclerosis
Publicado: (1906)

Arteriosclerosis and Diabetes
Publicado: (1925)

Antisclerosin in Arteriosclerosis
por: Goldschmidt, S.
Publicado: (1904)

Athletics and Arteriosclerosis
Publicado: (1904)

Treatment of Arteriosclerosis
Publicado: (1907)

Test for Arteriosclerosis
Publicado: (1914)

miR-21 regulates vascular smooth muscle cell function in arteriosclerosis obliterans of lower extremities through AKT and ERK1/2 pathways
por: Huang, Shuichuan, et al.
Publicado: (2018)

The clinical aspects of arteriosclerosis
por: Rinzler, Seymour H.
Publicado: (1957)

MiR-142-3p Attenuates the Migration of CD4(+) T Cells through Regulating Actin Cytoskeleton via RAC1 and ROCK2 in Arteriosclerosis Obliterans
por: Liu, Jiawei, et al.
Publicado: (2014)

Orthotopic kidney transplantation from a living renal donor after interventional therapy for bilateral arteriosclerosis obliterans of the iliac arteries: A case report and literature review
por: Ohyama, Takehiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n97jd8nbvmsftschbd0i459rk0